• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

LY2857785 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5764318

LY2857785 is a type I competitive and reversible ATP kinase inhibitor against CDK7/CDK8/CDK9 (IC50s: 246nM/16nM/11nM). More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
LY2857785, Inhibitor
Full Product Name
LY2857785
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
448.6
Solubility
DMSO: 10mg/mL (22.29mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C26H36N6O
SMILES
CC(C)c1c(cc(cc2)-c3ccnc(N[C@H](CC4)CC[C@@H]4NC4CCOCC4)n3)c2nn1C
CAS Number
1619903-54-6
Cell Research
Solid tumor cells are plated in poly-D-lysine coated and hematologic cell lines are seeded in noncoated 96-well plates overnight before being treated with LY2857785. Solid tumor cells are fixed with Prefer for 20 minutes at room temperature and permeated with 0.1% Triton X-100 in PBS for 15 minutes. Caspase-3 expression is measured by immunofluorescence with anti-activated caspase-3. Terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) activity is measured with In Situ Cell Death Detection Kit. Both assays are analyzed on Acumen Explorer laser-scanning fluorescence microplate cytometer. Hematologic tumor cells are assayed for cell viability with CellTiter-Glo Luminescent Cell Viability Assay.
Kinase Assay
CDK7 and CDK9 reaction mixtures contain 10mM Tris-HCl (pH 7.4), 10mM HEPES, 5mM DTT, 10uM ATP, 0.5uCi 33p-ATP, 10mM MnCl2, 150mM NaCl, 0.01% Triton X-100, 2% DMSO, 0.05mM CDK7/9ptide, and 2nM CDK7/Mat1/cyclin H, or 2nM CDK9/cyclin T1, respectively. CDK8/cyclin C reaction is performed in HEPES 30mM, DTT 2mM, MgCl2 5mM, 0.015% Triton X-100, 5uM ATP, and 400nM of RBER-CHKStide containing 20nM of enzyme. LY2857785 in DMSO is diluted serially 1:3 for dose-response. Reactions are carried out in 96-well polystyrene plates. The reactions are incubated at room temperature for 60 minutes and followed by termination with 10% H3PO4 or 10% trichloroacetic acid (TCA). For the filter binding assay, reactions are transferred to 96-well filter plates and measured by Microbeta scintillation counter. For ADP Transcreener Fluorescent Polarization Assays, reactions are quenched with ADP detection mix, incubated 2 hours at room temperature and then FP is measured at lambdaex=610nM, lambdaem=670nM on a Tecan Ultra 384 plate reader. The concentration of ADP product is calculated from millipolarization (uP) using a prepared ADP/ATP dilution series as a standard curve. Kinase profiling are carried out in 96-well polystyrene plates. Briefly, in a final volume of 25uL the enzyme is incubated with the appropriate buffer, peptide substrate, and the diluted LY2857785. Reactions are initiated by the addition of ATP/[33P] and the ATP mix is incubated at room temperature for 40 minutes. Reactions are quenched with the addition of 5uL of 3% phosphoric acid, 10uL of the reaction are spotted onto a filter mat, washed 3 times for 5 minutes in 75mM phosphoric acid and once in methanol. Once the filters are dry, they are submitted to scintillation counting.

Product Categories/Family for LY2857785, inhibitor

Product References and Citations for LY2857785, inhibitor

Yin T, et al. A novel CDK9 inhibitor shows potent antitumor efficacy in preclinical hematologic tumor models. Mol Cancer Ther. 2014 Jun;13(6):1442-56. Mol Cancer Ther. 2014 Jun;13(6):1442-56.

Other Notes

Small volumes of LY2857785, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for LY2857785 purchase

MBS5764318 is an inhibitor targeting LY2857785.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000